| Literature DB >> 28209762 |
Nancy S Bae1, Andrew P Seberg2, Leslie P Carroll3, Mark J Swanson4,3.
Abstract
The yeast Saccharomyces cerevisiae responds to amino acid deprivation by activating a pathway conserved in eukaryotes to overcome the starvation stress. We have screened the entire yeast heterozygous deletion collection to identify strains haploinsufficient for growth in the presence of sulfometuron methyl, which causes starvation for isoleucine and valine. We have discovered that cells devoid of MET15 are sensitive to sulfometuron methyl, and loss of heterozygosity at the MET15 locus can complicate screening the heterozygous deletion collection. We identified 138 cases of loss of heterozygosity in this screen. After eliminating the issues of the MET15 loss of heterozygosity, strains isolated from the collection were retested on sulfometuron methyl. To determine the general effect of the mutations for a starvation response, SMM-sensitive strains were tested for the ability to grow in the presence of canavanine, which induces arginine starvation, and strains that were MET15 were also tested for growth in the presence of ethionine, which causes methionine starvation. Many of the genes identified in our study were not previously identified as starvation-responsive genes, including a number of essential genes that are not easily screened in a systematic way. The genes identified span a broad range of biological functions, including many involved in some level of gene expression. Several unnamed proteins have also been identified, giving a clue as to possible functions of the encoded proteins.Entities:
Keywords: GCN4; Saccharomyces cerevisiae; amino acid starvation; general amino acid control; sulfometuron methyl
Mesh:
Substances:
Year: 2017 PMID: 28209762 PMCID: PMC5386856 DOI: 10.1534/g3.116.037416
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 2Screening for strains haploinsufficient for growth in the presence of SMM. Each panel shows a diagram of the dilution series performed as well as plates with representative data. (A) Heterozygous deletion strains from the library microtiters were transferred to microtiters with fresh YPD medium containing G418 sulfate. Every four columns of strains from each library microtiter (numbered) were transferred and diluted 20-fold per new microtiter. Two more 20-fold serial dilutions were made for each strain. For each strain, 5 µl of each dilution (20×, 400×, and 8000×) were spotted onto SC control and SC-ile-val + SMM (1 and 2 µg/ml) agar media. BY4743 (wild type), GCN4/gcn4∆, and gcn4∆/gcn4∆ control strains were grown in separate microtiters in YPD, and diluted samples were included on every agar plate. Plates were photographed after 3, 4, and 5 d of growth. Representative data are shown using the first four columns from microtiter #211 of the heterozygous deletion collection (the photographs show SC and SC-ile-val + 1 µg/ml SMM after 3 d of growth and the SC-ile-val + 2 µg/ml SMM after 4 d of growth). Three strains that displayed significant growth defects in the presence of SMM are indicated: TAF14/taf14∆ (indicated with the red boxes) on both the 1 and 2 µg/ml SMM plates, and MED8/med8∆ (blue box) and RPL33A/rpl33a∆ (green box) on the 2 µg/ml SMM plate. (B) All SMM-sensitive heterozygotes from the library were collected and organized into new microtiters. Two columns from each of the SMM-sensitive candidate microtiters (indicated by numbers 1 and 2 as an example) were used to inoculate YPD + G418 sulfate in fresh microtiters. After 2 d of growth, the strains were serially diluted 10-fold to 100,000× dilution. For each strain, 5 µl of each dilution were spotted onto SC control and SC-ile-val + SMM (1, 2, and 3 µg/ml) agar media. BY4743 (wild type), GCN4/gcn4∆, and gcn4∆/gcn4∆ control strains were grown in separate microtiters in YPD, and diluted samples were included on every agar plate. The photographs shown were taken after 4 d (SC and SC-ile-val + 2 µg/ml SMM) or 5 d (SC-ile-val + 3 µg/ml SMM) of growth. The three strains depicted in (A) are shown here again (the SC-ile-val + 1 µg/ml SMM plate has been omitted for clarity): TAF14/taf14∆ (indicated with the red boxes), MED8/med8∆ (blue boxes), and RPL33A/rpl33a∆ (green boxes).
Figure 1A GCN4/gcn4Δ strain is haploinsufficient for growth in the presence of SMM, ETH, and CAN. Ten-fold serial dilutions of wild-type BY4743 or GCN4/gcn4Δ cells were plated onto complete or amino acid starvation medium. (A) Cells were plated onto SC control plates and SC-ile-val plates containing SMM at the concentrations shown to induce starvation for isoleucine and valine. (B) Cells were plated onto SC-met-cys control plates (see the results section Identification of genes causing haploinsufficiency for growth on SMM for details) and SC-met-cys plates containing ETH at the concentrations shown to induce starvation for methionine. (C) Cells were plated onto SC control plates and SC-arg plates containing CAN at the concentrations shown to induce starvation for arginine.
Figure 3Loss of heterozygosity at the MET15 locus and effects on SMM phenotypes. (A) Homozygous met15∆ strains are sensitive to SMM. The MET15/MET15, MET15/met15∆ (met15Δ0; the strain is BY4743), met15∆/met15∆ (met15Δ::kanMX4/met15Δ0, which is the met15Δ strain from the heterozygous collection), and GCN4/gcn4∆ strains were grown in YPD in a 96-well microtiter for 2 d at 30°. Ten-fold serial dilutions were made and 5 µl of undiluted and diluted samples were spotted onto SC control and SC-ile-val + 3 µg/ml SMM media. The plates were incubated at 30° and photographed after 3 d of growth. (B) A diagram of the MET15 locus and oligonucleotides for yeast colony PCR are shown. The primer depicted by the orange arrow (upstream primer, see Materials and Methods) is upstream of the MET15 locus and will bind to both MET15 and met15∆ alleles. The primer indicated by the blue arrow (ORF primer, see Materials and Methods) binds to the MET15 coding region, and it will not bind to the met15∆ allele. With the upstream primer, the MET15 allele will yield a PCR product of ∼1 kbp. The primer depicted by the green arrow (downstream primer, see Materials and Methods) binds to a region beyond the MET15 stop codon. This region is present in both the MET15 and met15∆ alleles, but conditions for PCR were performed such that only the shorter, met15∆-generated PCR product was amplified. (C) A representative gel of the MET15 locus PCR from candidate and control strains is shown. Sample names are listed above the agarose gel image. Negative (no cells) and positive (BY4743 with both the MET15 and met15∆ alleles) controls were included in each gel. Methionine phenotypes are listed for each strain below the agarose gel (+, methionine prototroph; −, methionine auxotroph). Several strains show LOH at the MET15 locus as indicated by a single band on the gel.
Figure 4Circumventing the effects of LOH at MET15. (A) For all phenotypically Met− deletion strains that were met15Δ/met15Δ by PCR analysis, the met15Δ::kanMX4/met15Δ0 from the deletion strain collection was used as the wild-type control on SC-ile-val + SMM (2 µg/ml shown) containing medium. Cells were treated as in Figure 3A. As an example, the RBG1/rbg1Δ strain is not significantly more SMM-sensitive than the met15Δ::kanMX4/met15Δ0 control strain. In contrast, the VMA11/vma11Δ and HFI1/hfi1Δ strains are significantly more SMM-sensitive than the control. (B) Removal of methionine and cysteine from the growth medium reduces the effectiveness of SMM. The wild-type BY4743 and the GCN4/gcn4Δ strains were grown and treated as in Figure 3A, except that the medium was SC-met-cys without or with 2 or 4 µg/ml SMM. In SC-met-cys, the GCN4/gcn4Δ strain does not display any phenotype at 2 µg/ml SMM, and a moderate phenotype at 4 µg/ml SMM (compare to Figure 1, top panels). (C) For all phenotypically Met+ strains, SMM sensitivity was monitored on SC-met-cys-ile-val medium without or with SMM (6 and 8 µg/ml SMM are shown). Cells were treated as in Figure 3A, except that growth media were SC-met-cys and SC-met-cys-ile-val with SMM. The MON2/mon2Δ strain that had originally shown an SMM-sensitive phenotype is no longer sensitive on SC-met-cys-ile-val with SMM, although the RPL33A/rpl33aΔ, YPL142C/ypl142cΔ, and TAF14/taf14Δ strains remain sensitive to SMM. (D) The diagram indicates the general functional categories for genes identified in the SMM-sensitivity screen as listed in Table 1. The genes from the category “Other” have been omitted.
SMM-sensitive heterozygous deletion mutants
| ORF ID | Gene | SGD Description | Phenotypes |
|---|---|---|---|
| Transcription | |||
| YEL009C | bZIP transcriptional activator of amino acid biosynthetic genes; activator responds to amino acid starvation | M+, E, C, v | |
| YPR104C | Regulator of ribosomal protein (RP) transcription; has forkhead associated domain that binds phosphorylated proteins; recruits coactivator Ifh1p or corepressor Crf1p to RP gene promoters | M+, C, i | |
| YBL014C | Component of the core factor (CF) rDNA transcription factor complex; CF is required for transcription of 35S rRNA genes by RNA polymerase I and is composed of Rrn6p, Rrn7p, and Rrn11p | M+, C, i | |
| YBL005W | Transcriptional activator of the pleiotropic drug resistance network; regulates expression of ATP-binding cassette (ABC) transporters | M+, E, C, v | |
| YDL020C | Transcription factor that stimulates expression of proteasome genes; Rpn4p levels are in turn regulated by the 26S proteasome in a negative feedback control mechanism; | M+, C, v | |
| YHR143W-A | RNA polymerase subunit ABC10-α, found in RNA pol I, II, and III | M+, i | |
| YPL254W | Adaptor protein required for structural integrity of the SAGA complex, a histone acetyltransferase-coactivator complex that is involved in global regulation of gene expression through acetylation and transcription functions | M−, C, v | |
| YOL148C | Subunit of the SAGA transcriptional regulatory complex | M−, C, v | |
| YDR145W | Subunit (61/68 kD) of TFIID and SAGA complexes; involved in RNA polymerase II transcription initiation and in chromatin modification, similar to histone H2A | M+, E, C, i | |
| YBR198C | Subunit (90 kDa) of TFIID and SAGA complexes; involved in RNA polymerase II transcription initiation and in chromatin modification | M+, E, C, i | |
| YPL129W | Subunit of TFIID, TFIIF, INO80, SWI/SNF, and NuA3 complexes; involved in RNA polymerase II transcription initiation and in chromatin modification | M+, E, C, v | |
| YMR091C | Component of the RSC chromatin remodeling complex | M+, C, v | |
| YNR052C | RNase of the DEDD superfamily; subunit of the Ccr4-Not complex that mediates 3′–5′ mRNA deadenylation | M−, C, v | |
| YBR095C | Component of the histone deacetylase Rpd3L complex | M+, E, C, v | |
| mRNA processing/export | |||
| YDR364C | Pre-mRNA splicing factor | M+, E, C, v | |
| YNL004W | Poly(A+) RNA-binding protein; key surveillance factor for the selective export of spliced mRNAs from the nucleus to the cytoplasm | M−, v | |
| YDR228C | mRNA 3′ end processing factor; essential component of cleavage and polyadenylation factor IA (CF IA), involved in pre-mRNA 3′ end processing and in transcription termination | M+, i | |
| YMR061W | Component of the cleavage and polyadenylation factor 1 (CF1); CF1, composed of the CF1A complex (Rna14p, Rna15p, Clp1p, Pcf11p) and Hrp1, is involved in cleavage and polyadenylation of mRNA 3′ ends | M−, C, i | |
| YLR293C | Ran GTPase; GTP binding protein (mammalian Ranp homolog) involved in the maintenance of nuclear organization, RNA processing and transport | M+, C, i | |
| Translation | |||
| YKL009W | Protein involved in mRNA turnover and ribosome assembly | M−, C, v | |
| YPL143W | Ribosomal 60S subunit protein L33A; nearly identical to RPL33B | M+, E, C, i | |
| YDR500C | Ribosomal 60S subunit protein L37B; required for processing of 27SB pre-rRNA and formation of stable 66S assembly intermediates; nearly identical to RPL37A | M+, E, C, v | |
| YDR064W | Protein component of the small (40S) ribosomal subunit | M+, E, i | |
| YOR182C | Protein component of the small (40S) ribosomal subunit; identical to RPS30A | M+, E, C, v | |
| YPL090C | Protein component of the small (40S) ribosomal subunit; identical to RPS6B | M−, v | |
| YOR096W | Protein component of the small (40S) ribosomal subunit; nearly identical to RPS7B | M+, E, C, v | |
| YPL183W-A | Protein involved in translation; mutants have defects in biogenesis of nuclear ribosomes; sequence similar to prokaryotic ribosomal protein L36 | M−, C, v | |
| Protein kinase and phosphatase subunits | |||
| YER133W | Type 1 S/T protein phosphatase catalytic subunit; cleavage and polyadenylation factor (CPF) component | M+, E, C, i | |
| YDR028C | Regulatory subunit of type 1 protein phosphatase Glc7p | M+, v | |
| YAR018C | Nonessential serine/threonine protein kinase; possible role in DNA damage response | M−, C, v | |
| YBL046W | Regulatory subunit of protein phosphatase PP4; presence of Psy4p in the PP4 complex is required for dephosphorylation of the histone variant H2AX during recovery from the DNA damage checkpoint | M+, E, C, v | |
| Protein degradation | |||
| YDR049W | Component of a Cdc48p-complex involved in protein quality control; contributes to ER-associated degradation (ERAD) of specific substrates; forms a mitochondrially-associated complex with Cdc48p and Npl4p under oxidative stress that is required for ubiquitin-mediated mitochondria-associated protein degradation (MAD) | M−, C, v | |
| YGL116W | Activator of anaphase-promoting complex/cyclosome (APC/C); APC/C is required for metaphase/anaphase transition | M+, E, C, i | |
| Vacuole/ | |||
| YPL234C | Vacuolar ATPase | M−, C, v | |
| YHR026W | Subunit c′′ of the vacuolar ATPase; v-ATPase functions in acidification of the vacuole; one of three proteolipid subunits of the | M−, C, v | |
| YEL027W | Proteolipid subunit c of the | M+, C, v | |
| YCL005W-A | Vacuolar H+ ATPase subunit e of the V-ATPase | M+, v | |
| Protein trafficking | |||
| YDL193W | Forms dehydrodolichyl diphosphate syntase complex with RER2 or SRT1; Nus1p may be involved in protein trafficking | M+, E, C, i | |
| YDR483W | α1,2-mannosyltransferase of the Golgi; involved in protein mannosylation | M−, C, v | |
| YBR290W | Heavy metal ion homeostasis protein; facilitates trafficking of Smf1p and Smf2p metal transporters to vacuole where they are degraded; controls metal ion transport, prevents metal hyper-accumulation, functions in copper detoxification | M+, C, v | |
| Metabolic pathway | |||
| YCL009C | Regulatory subunit of acetolactate synthase; acetolactate synthase catalyzes the first step of branched-chain amino acid biosynthesis; enhances activity of the Ilv2p catalytic subunit | M+, v | |
| YLR303W | M−, v | ||
| YFR055W | β-lyase involved in the production of thiols | M+, v | |
| YDR531W | Pantothenate kinase, ATP:D-pantothenate 4′-phosphotransferase; catalyzes the first committed step in the universal biosynthetic pathway for synthesis of coenzyme A (CoA) | M−, i | |
| YJL130C | Bifunctional carbamoylphosphate synthetase/aspartate transcarbamylase; catalyzes the first two enzymatic steps in the | M+, E, v | |
| YHR128W | Uracil phosphoribosyltransferase; synthesizes UMP from uracil; involved in the pyrimidine salvage pathway | M+, C, i | |
| Drug resistance | |||
| YDR011W | Plasma membrane ATP-binding cassette (ABC) transporter; multidrug transporter involved in multidrug resistance and resistance to singlet oxygen species | M+, v | |
| Cytoskeleton | |||
| YNR035C | Subunit of the ARP2/3 complex; ARP2/3 is required for the motility and integrity of cortical actin patches | M−, C, i | |
| YML085C | α-tubulin; associates with β-tubulin (Tub2p) to form tubulin dimer, which polymerizes to form microtubules | M+, C, i | |
| Amino acid sensor | |||
| YNL008C | Subunit of the nuclear inner membrane Asi ubiquitin ligase complex; acts with Asi1p and Asi2p to ensure the fidelity of SPS-sensor signaling | M−, C, v | |
| YFR029W | Component of the SPS plasma membrane amino acid sensor system; senses external amino acid concentration and transmits intracellular signals that result in regulation of expression of amino acid permease genes | M−, C, i | |
| Unfolded protein | |||
| YJL008C | Subunit of the cytosolic chaperonin Cct ring complex; related to Tcp1p, required for the assembly of actin and tubulins | M+, C, i | |
| YJL082W | Protein required for clearance of inclusion bodies; localizes to the inclusion bodies formed under protein mis-folding stress | M+, C, v | |
| YBL075C | ATPase involved in protein folding and the response to stress; plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation | M−, C, v | |
| Other | |||
| YBR156C | Subunit of the conserved chromosomal passenger complex (CPC); complex regulates kinetochore-microtubule attachments, activation of the spindle tension checkpoint, and mitotic spindle disassembly | M+, E, v | |
| YNL012W | Meiosis-specific prospore protein; required for meiotic spindle pole body duplication and separation | M−, C, v | |
| YNL013C | Dubious open reading frame; partially overlaps the verified ORF | M−, C, v | |
| YER177W | 14-3-3 protein, major isoform; controls proteome at posttranscriptional level, binds proteins and DNA, involved in regulation of exocytosis, vesicle transport, Ras/MAPK and rapamycin-sensitive signaling, aggresome formation, spindle position checkpoint | M−, v | |
| YGL110C | Protein of unknown function; has a CUE domain that binds ubiquitin, which may facilitate intramolecular monoubiquitination | M−, C, v | |
| YDR516C | Nonessential protein of unknown function; required for transcriptional induction of the early meiotic-specific transcription factor IME1; required for sporulation | M+, E, v | |
| YGL168W | Protein of unknown function; reported null mutant phenotype of hydroxyurea sensitivity may be due to effects on overlapping | M+, E, C, v | |
| YGR289C | High-affinity maltose transporter (α-glucoside transporter); broad substrate specificity that includes maltotriose | M+, E, C, v | |
| YBR185C | Membrane-associated mitochondrial ribosome receptor | M−, C, v | |
| YBR100W | Subunit of structure-specific Mms4p-Mus81p endonuclease; cleaves branched DNA; involved in recombination, DNA repair, and joint molecule formation/resolution during meiotic recombination | M+, E, C, v | |
| YPL142C | Dubious open reading frame; completely overlaps the verified ORF | M+, E, C, i | |
| YNL028W | Dubious open reading frame; partly overlaps verified ORF | M−, C, v | |
| YBR221W-A | Putative protein of unknown function; identified by expression profiling and mass spectrometry | M−, v | |
| YHL015W-A | Putative protein of unknown function | M−, v | |
| YBR196C-A | Putative protein of unknown function; identified by fungal homology and RT-PCR | M−, C, v | |
| YCR061W | Protein of unknown function; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm in a punctate pattern | M+, C, v | |
| YBL065W | Dubious open reading frame; partially overlaps verified ORF | M+, E, C, v | |
| YJR039W | Putative protein of unknown function; the authentic, nontagged protein is detected in highly purified mitochondria in high-throughput studies | M+, E, C, v | |
Genes are grouped into general functional categories. SGD descriptions are derived from the Saccharomyces Genome Database. Phenotypes are: M−, Met− (methionine auxotroph); M+, Met+ (methionine prototroph); E, ethionine sensitive (only M+ strains can be tested for ethionine sensitivity); C, canavanine sensitive; i, reported on SGD to be an inviable null mutation in large-scale surveys; v, reported on SGD to be a viable null deletion in large-scale surveys.
Viability not stated on SGD, but the haploid deletion and homozygous null strains exist.
Data in large-scale surveys include both viable and inviable phenotypes. Cells with a deletion of the CDC40 or POP2 genes in the S288C background that BY4743 was derived are viable.
GO annotation enrichment
| Category | Ontology | GO ID | In Category from Cluster | Intersection | Category Size | p-Value |
|---|---|---|---|---|---|---|
| Hydrogen ion transmembrane transporter activity | Molecular function | GO:0015078 | 4 | 15 | 1.62E−05 | |
| Amino acid binding | Molecular function | GO:0016597 | 2 | 4 | 6.94E−04 | |
| ATP hydrolysis coupled proton transport | Biological process | GO:0015991 | 4 | 17 | 2.779E−05 | |
| Histone acetylation | Biological process | GO:0016573 | 5 | 42 | 8.327E−05 | |
| Vacuolar acidification | Biological process | GO:0007035 | 4 | 26 | 1.61E−04 | |
| Transcription, DNA-dependent | Biological process | GO:0006351 | 15 | 540 | 5.83E−04 | |
| Glycogen metabolic process | Biological process | GO:0005977 | 3 | 16 | 6.29E−04 | |
| RNA polymerase II transcriptional preinitiation complex assembly | Biological process | GO:0051123 | 3 | 16 | 6.29E−04 | |
| Regulation of carbohydrate metabolic process | Biological process | GO:0006109 | 2 | 4 | 6.94E−04 | |
| Regulation of transcription, DNA-dependent | Biological process | GO:0006355 | 14 | 507 | 9.70E−04 | |
| Proton transport | Biological process | GO:0015992 | 4 | 41 | 9.71E−04 | |
| Proton-transporting V-type ATPase, | Cellular component | GO:0033179 | 4 | 5 | 6.45E−08 | |
| Vacuolar proton-transporting V-type ATPase, | Cellular component | GO:0000220 | 4 | 7 | 4.44E−07 | |
| SLIK (SAGA-like) complex | Cellular component | GO:0046695 | 4 | 17 | 2.78E−05 | |
| Proton-transporting two-sector ATPase complex, proton-transporting domain | Cellular component | GO:0033177 | 3 | 7 | 4.22E−05 | |
| SAGA complex | Cellular component | GO:0000124 | 4 | 20 | 5.52E−05 | |
| Transcription factor TFIID complex | Cellular component | GO:0005669 | 3 | 15 | 5.15E−04 | |
| Intracellular | Cellular component | GO:0005622 | 12 | 381 | 7.53E−04 |
Overrepresented biological processes for all genes resulting in haploinsufficiency on SMM media according to the FunSpec program, using a p-value cutoff of 0.001 (Robinson ). The genes identified in this screen are listed (In Category from Cluster).
Figure 5Examples of ETH and CAN haploinsufficient phenotypes. (A) ETH phenotypes of all phenotypically Met+ strains were tested. The cells were treated as in Figure 4B, except that they were plated onto SC-met-cys + ETH (10 and 15 µg/ml are shown). The MON2/mon2Δ strain grows similarly to the BY4743 wild type. The RPL33A/rpl33aΔ, YPL142C/ypl142cΔ, and TAF14/taf14Δ strains are sensitive to ETH. (B) All SMM-sensitive strains were tested for growth in the presence of CAN. Cells were treated as in Figure 3A, except they were plated onto SC-arg + CAN (3 and 4 µg/ml are shown). The met15Δ::kanMX4/met15Δ0 strain is no more sensitive to CAN than the BY4743 wild type (top panels). The RPL33A/rpl33aΔ and YPL142C/ypl142cΔ strains are both CAN-sensitive but the TAF14/taf14Δ strain is not.
Figure 6Excess aspartate exacerbates SMM-induced starvation. BY4743 wild-type cells and gcn4Δ/gcn4Δ cells treated as in Figure 3A, except that they were plated onto SC, SC-ile-val with 2 µg/ml SMM (top panels), SC with 2 g/liter aspartate added, and SC-ile-val with 2 µg/ml SMM and 2 g/liter aspartate added (bottom panels). The BY4743 cells are unaffected by addition of excess aspartate in the SC medium. When starved for isoleucine and valine, the growth of the BY4743 strain is inhibited, and the growth is made worse by the presence of the excess aspartate. The gcn4Δ/gcn4Δ strain is included as a control to show that the SMM is working.